Section ENVIRONMENT
TOPIC

GENESIS Pharma
“Green Pharma Operations”

The initiative aims to:

  • Reduce CO₂ emissions from operations and mobility
  • Improve energy efficiency and conserve natural resources
  • Strengthen circular economy practices
  • Foster environmental awareness among employees
  • Introduce sustainable practices within the supply chain

The initiative addresses all company stakeholders, reflecting the strategic importance of sustainability across the GENESIS Pharma ecosystem:

  • Employees: Primary beneficiaries, engaged through awareness, training, and participation in green practices
  • Management & Leadership: Integrating ESG criteria into decision-making and operational strategy
  • Suppliers & Logistics Partners: Adoption of responsible practices, ESG standards, and sustainable solutions
  • International Partners & Pharma Companies: Alignment on environmental commitments and standards
  • Medical Community & Healthcare Professionals: Stakeholders influenced by responsible industry practices
  • Patients (indirectly): Through contribution to a more sustainable healthcare system
  • Wider Society & Communities: Via reduced environmental impact and increased awareness
  • Regulatory Authorities & Institutions: Ensuring compliance and contribution to sustainability goals
  • ESG Organizations (e.g., QualityNet Foundation): Transparency and evaluation of corporate responsibility
  • Investors & ESG Stakeholders: Assessing environmental performance and responsible operations
  • Business Community: As a best practice example within the pharmaceutical sector

Ongoing, long-term initiative with continuous development, KPI expansion, and increased engagement.

“Green Pharma Operations” was designed as a comprehensive environmental management framework aimed at systematically embedding sustainability principles across all company functions.

The approach shifts from isolated green initiatives to a structured, measurable, KPI-driven operating model aligned with ESG frameworks and international sustainability standards.

Implementation focuses on key pillars such as:

  • Energy efficiency
  • Carbon footprint reduction
  • Sustainable mobility
  • Responsible waste management
  • Integration of environmental criteria into the supply chain

At the same time, strong emphasis is placed on employee engagement through training and internal campaigns, fostering a culture of environmental responsibility.

Key innovation elements include:

  • A holistic approach covering all operations
  • Systematic monitoring of environmental KPIs
  • Integration of sustainability into daily operations and decision-making
  • Activation of both internal and external ecosystems

The initiative accelerates GENESIS Pharma’s transition to a more sustainable business model while generating long-term environmental and social value.

Key KPIs include:

  • Reduction of CO₂ emissions and energy consumption
  • Increased recycling and reduced waste
  • Sustainable mobility and green fleet
  • Employee participation and training
  • ESG adoption across the supply chain

The initiative is strengthened through collaborations with specialized organizations:

  • Certified recycling and waste management providers
  • ESG and environmental consultants (for Scope 1, 2, 3 footprint tracking)
  • Suppliers and logistics partners adopting sustainable practices
  • Sustainability organizations (e.g., QualityNet Foundation)

This collaborative model enhances collective impact and alignment with international sustainability standards.

Employees play a central role as agents of change. Participation is encouraged through:

  • Training programs and awareness sessions
  • Internal campaigns (e.g., “Go Green at Work”)
  • Recycling and waste reduction programs
  • Environmental volunteering (tree planting, clean-ups)
  • Daily sustainable practices (paper reduction, energy saving, responsible mobility)

The company tracks participation and engagement levels, using feedback to continuously improve initiatives.

Primarily implemented at GENESIS Pharma offices in Greece (Athens), with extended impact across:

  • Remote/hybrid workforce
  • Supply chain partners (local and international)
  • External environmental activities (e.g., tree planting, clean-ups)

Environmental Impact:

  • Reduced paper consumption through digitalization
  • Increased recycling rates
  • Improved energy efficiency
  • Reduced CO₂ emissions via fewer physical meetings and travel

Impact on Employees:

  • High participation in ESG initiatives
  • Increased environmental awareness
  • Higher engagement levels
  • Stronger culture of responsibility

Impact on Supply Chain:

  • Increased ESG-aligned partnerships
  • Adoption of sustainable logistics solutions
  • Dissemination of best practices

Overall Impact:

  • Reduced Environmental Footprint
  • Strengthened corporate reputation
  • Positive multiplier effect across stakeholders
  • Reduced operating costs (energy, materials, travel)
  • Improved operational efficiency through digitalization
  • Optimized fleet management
  • Enhanced ESG performance and reporting
  • Compliance with European sustainability frameworks (e.g., CSRD readiness)
  • Stronger corporate reputation and ESG rankings
  • Competitive advantage in the pharmaceutical sector
  • Increased employee engagement and retention
  • Stronger stakeholder trust

Return on Investment (ROI)

1. Financial ROI:

  • Lower OPEX from energy savings, reduced paper use, optimized travel
  • Resource savings through digital workflows

2. Operational ROI:

  • Improved efficiency and automation
  • Better ESG data management

3. Strategic / ESG ROI:

  • Improved ESG ratings
  • Increased investor attractiveness
  • Regulatory readiness

4. Reputational ROI:

  • Stronger sustainability brand
  • Improved rankings (e.g., Most Sustainable Companies in Greece)

5. Human Capital ROI:

  • Higher productivity and engagement
  • Strong employer branding

6. Long-Term ROI:

  • Reduced Environmental Risks
  • Stronger competitive positioning
  • Increased stakeholder trust